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Abstract
Background: The International Liaison Committee on Resuscitation (ILCOR) now recommends therapeutic
hypothermia (TH) (33°C for 12-24 hours) as soon as possible for patients who remain comatose after resuscitation
from shockable rhythm in out-of-hospital cardiac arrest and that it be considered for non shockable rhythms. The
optimal timing of TH is still uncertain. Laboratory data have suggested that there is significantly decreased
neurological injury if cooling is initiated during CPR. In addition, peri-arrest cooling may increase the rate of
successful defibrillation. This study aims to determine whether paramedic cooling during CPR improves outcome
compared standard treatment in patients who are being resuscitated from out-of-hospital cardiac arrest.
Methods/Design: This paper describes the methodology for a definitive multi-centre, randomised, controlled trial
of paramedic cooling during CPR compared with standard treatment. Paramedic cooling during CPR will be
achieved using a rapid infusion of large volume (20-40 mL/kg to a maximum of 2 litres) ice-cold (4°C) normal
saline.
The primary outcome measure is survival at hospital discharge. Secondary outcome measures are rates of return of
spontaneous circulation, rate of survival to hospital admission, temperature on arrival at hospital, and 12 month
quality of life of survivors.
Discussion: This trial will test the effect of the administration of ice cold saline during CPR on survival outcomes. If
this simple treatment is found to improve outcomes, it will have generalisability to prehospital services globally.
Trial Registration: ClinicalTrials.gov: NCT01172678
Background
Cardiovascular disease is a leading cause of premature
death in Australia [1]. More than half of these deaths
(approximately 25,000 per year) occur prior to hospital
arrival. Despite sophisticated emergency medical service
responses to sudden cardiac arrest, less than half of sud-
den cardiac arrest patients are able to be resuscitated by
paramedics [2]. For those who are initially resuscitated
and transported to hospital, the prognosis is still poor,
particularly in rural areas [3]. Much of the mortality and
morbidity after hospital admission is due to the anoxic
brain injury sustained during the cardiac arrest [4].
One major recent advance in the treatment of severe
anoxic brain injury following out-of-hospital cardiac
arrest is therapeutic hypothermia (TH). When induced
after resuscitation, this treatment was shown to improve
neurological and overall outcomes in two randomized,
controlled clinical trials [5,6]. The International Liaison
Committee on Resuscitation (ILCOR) now recommends
TH (33°C for 12-24 hours) as soon as possible for
patients who remain comatose after resuscitation from
out-of-hospital cardiac arrest for shockable rhythms and
suggests that this therapy be considered for non shock-
able rhythms and in-hospital arrests [7,8].
The optimal timing of TH is still uncertain. Labora-
tory data have suggested that there is significantly
decreased neurological injury if cooling is initiated dur-
ing CPR [9-11]. Clinical and laboratory trials over the
last three years have established that a rapid intravenous
infusion of a large volume (20-40 mL/kg) of ice-cold
fluid (i.e. normal saline) during CPR is a feasible and an
effective method of induction of mild TH [12]. This
* Correspondence: conordeasy@hotmail.com
1Ambulance Victoria, Victoria, Australia
Full list of author information is available at the end of the article
Deasy et al. BMC Emergency Medicine 2011, 11:17
http://www.biomedcentral.com/1471-227X/11/17
© 2011 Deasy et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.technique has become widely used as a cooling method
in the pre-hospital setting [13], the Emergency Depart-
ment [14] and the Intensive Care Unit [15].
Previously, a randomised, controlled trial comparing
paramedic cooling after return of spontaneous circula-
tion (ROSC) with cooling in the emergency department
was conducted in Melbourne. The study was stopped at
the interim analysis due to a lack of difference in the
primary outcome measure (outcome at hospital dis-
charge) between the two groups [16]. Analysis of the
data revealed that paramedics infused an average of
1000 mL ambient temperature saline during CPR prior
to return of a spontaneous circulation as part of stan-
dard paramedic treatment and that cooling began
approximately 30 minutes after paramedic arrival and
only just prior to hospital cooling. Although there was a
decrease in the core temperatures of the patients on
arrival at the ED, this was a transient effect lasting only
approximately 20 minutes. Subsequently, the cooling
curves of the patients in both groups were identical.
Thus, it was considered unlikely that this transient dif-
ference in core temperature could have a measurable
effect on outcomes.
Further laboratory [17,18] and clinical research [19,20]
has suggested that paramedic cooling during CPR is fea-
sible and should be tested in large clinical trials. Bod-
dicker et al [17] examined the success rates of
defibrillation in swine cooled to different temperatures
and found first-shock defibrillation success was highest
in the hypothermia (33°C) group suggesting mild
hypothermia may have a beneficial anti-arrhythmic
effect, as well as a neuroprotective effect. Kämäräinen et
al [20] cooled adult patients with out-of-hospital cardiac
arrest during CPR and concluded that induction of ther-
apeutic hypothermia during pre-hospital CPR was easily
carried out and well tolerated. A study specifically
examining respiratory function in patients treated with
large volume, ice cold saline has indicated that there is
no adverse effect on respiratory function [21] Garrett et
al [22] in a retrospective analysis of a change in their
prehospital cardiac arrest treatment protocols allowing
intra-arrest induction of therapeutic hypothermia with
2000 ml of 4°C normal saline directly after obtaining
IV/IO access concluded that TH during the intra-arrest
period may improve the frequency of return of sponta-
neous circulation even at fluid volumes unlikely to
change core body temperature.
Given these supportive laboratory and preliminary
clinical data, we are conducting a definitive multi-centre,
randomised, controlled trial of paramedic cooling during
CPR compared with usual paramedic practice. We aim
to determine whether paramedic cooling during CPR
using a rapid infusion of large volume (20-40 mL/kg)
ice-cold (4°C) normal saline improves outcome
compared with standard treatment in patients who are
being resuscitated from out-of-hospital cardiac arrest.
Methods/Design
The RINSE trial is a prospective, multi-centre, rando-
mised, single blinded, controlled trial conducted by the
ambulance services of Victoria, Western Australia and
South Australia.
In the treatment arm, paramedics will undertake
immediate cooling on arrival and during cardiac arrest,
using a large volume (20 mL/kg up to 2 litres) intrave-
nous bolus of ice-cold saline. The saline infusion will be
continued after return of circulation and en-route to
hospital. In the control arm, patients will receive stan-
dard paramedic care, which includes the administration
of normal saline at ambient temperature and will be
cooled after arrival at the hospital (the current standard
of care in ambulances in Australasia).
Study sites
This is a three-centre funded study administered cen-
trally through the Monash University Department of
Epidemiology and Preventive Medicine with study sites
in Victoria (Victoria Ambulance and Monash Univer-
sity); South Australia (South Australia Ambulance Ser-
vice and Flinders University) and Western Australia (St
John Ambulance and University of Western Australia).
In Victoria, only MICA paramedics will enroll patients
whereas in WA and SA all paramedics (but not trans-
port officers) will recruit patients.
Inclusion/Exclusion Criteria
Paramedics will screen patients during cardiac arrest
and determine eligibility for enrolment. Adults 18 years
and over, in cardiac arrest on arrival of paramedics are
eligible for inclusion. Patients who are in cardiac arrest
following trauma, or who are obviously pregnant or who
are already hypothermic (tympanic temperature < 34.5°
C) will be excluded.
Randomisation
The ambulances will be provided with a set of randomi-
sation envelopes. Block randomization will be used with
instructions for immediate cooling therapy during CPR
or instructions for standard treatment. Standard treat-
ment includes cooling commenced at hospital as per
ILCOR recommendations [7,8]. The envelopes will be
randomised by computer-generated code into blocks of
ten, numbered externally, and then sealed within an
opaque envelope that conceals the treatment designa-
tion. All vehicles will carry two envelopes and as each is
used, it will be replaced at the earliest convenient time
from the remaining envelopes held at the ambulance
station. Randomisation will be stratified by state to
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hospital treatment.
Study Treatments
For patients randomised to paramedic cooling:
- Standard advanced cardiac life support
- Advanced Airway (Endotracheal Tube/Laryngeal
Mask Airway) and ventilation with 100% oxygen
- Infuse 20 mL/kg cold fluid via IV stat during CPR
- Measure temperature using tympanic probe
- If temperature > 34.5°C, infuse further 10 mL/kg stat
- After ROSC, infuse further 10-20 mL/kg (to a maxi-
mum of 2 litres total fluid) ice-cold saline
- If shivering occurs post resuscitation, administer
midazolam 2-5 mg IV and pancuronium 8 mg (Victoria
only)
For patients randomised to hospital cooling:
- Standard advanced cardiac life support
- Advanced Airway (Endotracheal Tube/Laryngeal
Mask Airway) and ventilation with 100% oxygen
- Measure temperature using tympanic probe
- Insert IV line and administer drugs as per protocol
- Fluid challenge with standard temperature saline
only as per current patient care guideline
- Post resuscitation: midazolam 1-5 mg only to main-
tain intubation as needed
- Pancuronium 8 mg only if intubation unable to be
maintained with midazolam (Victoria only)
After arrival at the Emergency Department, all
patients receive standard care which may include cool-
ing to 33°C for 24 hours.
Cooled Fluid
The saline will be carried in insulated containers which
are changed every shift. A thermometer is housed in
this container ensuring the fluid is of the desired
temperature.
Sample Size
This study consists of two parallel clinical trials, sepa-
rately testing the effect of paramedic cooling during
CPR in patients with a shockable rhythm (VF/VT) and
non-shockable rhythm (asystole/pulseless electrical
activity).
The primary outcome measure for post-VF arrest
patients is survival at hospital discharge. Data from the
Victorian Cardiac Arrest Register shows that patients
who are in ventricular fibrillation on arrival of parame-
dics have a 40% rate of return of spontaneous circula-
tion, and there was a 50% subsequent survival rate in
the previous Melbourne cooling trial [16]. The overall
current survival rate based on all participating states is
c i r c a2 0 % .W ep r o p o s et h a tar a p i di n f u s i o no fc o l dI V
fluid will increase the rate of return of spontaneous
circulation based on laboratory data cited above from
40% to 45%, and that this very early cooling will
increase the overall survival rate from 20% to 27%. With
80% power and a type 1 error of 0.05, the study requires
a sample size of 603 post VF-arrest patients in each arm
(1206 in total).
Randomization of patients with non-VF will occur
concurrently. The primary outcome measure for non-
VF/VT cardiac arrest patients is also survival at hospital
discharge. Currently, the outcome at hospital discharge
of these patients is 2% [3]. To demonstrate improved
outcomes to 5% (an absolute difference of 3%) requires
653 per group, a total of 1306 patients.
For both studies, secondary outcome measures are the
rates of return of spontaneous circulation [23], survival
to hospital admission on all patients, and quality of life
measured by telephone follow up at 12 months using
the Glasgow Outcome Scale Extended (GOSE) [24], EQ-
5D [25] and SF-12 Health Survey Summary Score [26].
Analysis will be based on “Intention-to-treat”.
Consent/Ethics
Given that patients in cardiac arrest are unconscious, it
is not possible to obtain informed consent prior to ran-
domisation. The Australian National Statement on Ethi-
cal Conduct in Human Research [27] is used as the
basis for ethical review across the three Australian states
involved in this trial. Section 2.3.6 states that a human
research ethics committee may grant waiver of consent
if (a) involvement in the research carries no more than
low risk, and (b) the benefits from the research justify
any risks of harm associated with not seeking consent,
and (c) it is impracticable to obtain consent and (d)
there is no known or likely reason for thinking that par-
ticipants would not have consented if they had been
asked. Sections 4.4.13 requires there be no reason to
believe that consent would not be forthcoming were it
requested, that the risks of harm are minimized, that
the project is not controversial and does not involve sig-
nificant moral or cultural sensitivities in the community.
Section 4.4.13 also requires that the research supports a
reasonable possibility of benefit over standard care, that
any risk or burden of the intervention to the participant
is justified by its potential benefits and that inclusion in
the research project is not contrary to the interests of
the participant. Section 4.4.14 requires that as soon as
reasonably possible, the participant and/or the partici-
pant’s relatives should be informed of the participant’s
inclusion in the research and of the option to withdraw
from it without any reduction in quality of care.
In addition, enrolment without consent is authorized
in Victoria under Section 42A of the Medical Treatment
Act. This states that a registered medical practitioner
may carry out, or supervise the carrying out of, a
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sent or authorisation if the practitioner believes on rea-
sonable grounds that the treatment is necessary, as a
matter of urgency (a) to save the patient’s life; or (b) to
prevent serious damage to the patient’s health. This
study meets the intent of this section of the Medical
Treatment Act since the treatment (cooling during
CPR) is a matter of urgency and has the intention of
saving life and preventing serious neurological injury.
Human research ethics committees in the three study
states have endorsed the study protocol In Victoria, the
Human Research Ethics Committee requested that the
Investigators send an explanatory letter to survivors to
advise them of enrolment in the study. This letter will
be sent about two months after the cardiac arrest to
ensure that they have recovered sufficiently to under-
stand the letter. For deceased patients, an explanatory
letter will be sent to the next-of-kin also about two
months after the cardiac arrest to ensure that they have
recovered somewhat from the grief of the death of the
relative. If a surviving patient objects to the collection of
data, then no further data from that time onwards will
be collected. Public engagement has been achieved
using media news releases on the trial and information
on the trial will also be provided to the public through
ambulance service’s subscriber newsletters and web
sites.
In Western Australia, the University of Western Aus-
tralia Human Research Ethics Committee requires that
that surviving participants are informed of their partici-
pation as soon as practicable.
Data Collection
All data relevant to the study is currently recorded by
paramedics immediately after the case as a Patient Care
Record. Furthermore, Victoria, Western Australia and
South Australia each have a cardiac arrest registry that
records the patient, event and outcome data consistent
with the Utstein criteria [23] for all OHCAs attended.
The Victorian Cardiac Arrest Registry currently con-
ducts a 12-month quality of life follow-up on all survi-
vors. Victorian survivors will therefore be contacted 12
months post cardiac arrest to complete a functional and
quality of life outcomes telephone questionnaire.
Data Safety Management
The Data Safety Monitoring Committee will undertake
an interim analysis after 600 post VF and 600 non-VF
patients have been enrolled in the study. The study will
be stopped if there is a significant difference in the two
arms (p < 0.001) at the interim analysis [28]. Given that
the majority of patients die at the scene or in the hospi-
tal, and recurrent cardiac arrest at any time is possible
with standard care, it is not considered appropriate to
report every death to the Data Safety Monitoring Group
as a serious adverse effect.
Funding
The study has been funded by a project grant from the
National Health and Medical Research Council
(NHMRC) (grant number 1010613).
Discussion
There are a number of factors that support the feasibil-
ity of this proposed trial. First, the Investigators have
successfully undertaken a number of previous studies of
therapeutic interventions in critically ill patients in the
pre-hospital setting [16,29-32]. Second, the ambulance
services in Victoria, Western Australia and South Aus-
tralia are well placed to undertake large clinical trials.
The paramedics in these states are highly trained and
able to successfully enrol patients using a computer-gen-
erated envelope randomisation strategy, and then imple-
ment the required treatment. Third, the ethical issues
associated with non-consent randomisation of uncon-
scious patients have been carefully considered by Ethics
Committees in each of the states. Our approach of
delayed or non-consent has been accepted in the pre-
vious trials cited above. There is now a framework
under the NHMRC that supports the conduct of such
trials.
There will be important differences between the study
protocol in Victoria, Western Australia and South Aus-
tralia owing to variations in standard operating proce-
d u r e sa n df o rt h i sr e a s o nas t r a t i f i e dr a n d o m i s a t i o n
approach has been adopted. Ambulance Victoria has a
different staffing structure whereby cardiac arrests are
attended by intensive care paramedics with a wider
scope of practice for airway intervention (intubation)
and drug administration.
The Victorian ambulance protocol allows for endotra-
cheal intubation while the South Australia and Western
Australian protocols allow for the use of either endotra-
cheal intubation or laryngeal mask airway. In addition,
the Victorian ambulance protocol allows the administra-
tion of midazolam 2-5 mg IV and pancuronium 8 mg
for sedation of patients in the post resuscitation phase
as a treatment option for patient shivering. This will not
be part of the Western Australia and South Australia
protocol, thus we will be able to ascertain the prevalence
of overt shivering following the infusion of cold fluids by
the paramedics. Thus, we will be able to assess whether
the suppression of shivering is important in the induc-
tion of therapeutic hypothermia by the measurement of
temperature at hospital arrival.
There is an urgent need to improve outcomes from
out-of-hospital cardiac arrest. The RINSE trial will test
the effect of administration of a bolus of 20 mL/kg of
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simple, inexpensive treatment is found to improve
patient outcomes it will be an important prehospital
intervention globally.
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